Cryotherapy for Post-Hemorrhoidectomy Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University
About this trial
This prospective, patient-blinded randomized controlled trial will be conducted at Kasr Al-Ainy Hospital, Cairo University. Adult patients with grade III or IV hemorrhoids undergoing elective surgery will be randomized (1:1) to either conventional hemorrhoidectomy or hemorrhoidectomy followed by intra-anal cryotherapy. All patients will undergo standardized preoperative assessment and receive the same postoperative analgesia and care. Postoperative pain will be assessed using the Visual Analogue Scale (VAS), with follow-up at postoperative day 2 and at 1, 2, 3, and 4 weeks.
Eligibility criteria
Qualifiers
Patients with with third or fourth degree haemorrhoids for elective Haemorrhoidectomy and their age greater than 18 years old.
Disqualifiers
Concurrent anal pathology (e.g., anal fissure, fistula, )
Patients planned for synchronous procedures
Patients with inflammatory bowel disease
Patients with impaired anal sphincter function or fecal incontinence
Trial design
Treatments tested in this trial
- Milligan-Morgan Hemorrhoidectomy with Cryotherapy
- Miligan-Morgan haemorroidectomy
Treatment groups
114 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov